Zhenfeng Lu
Overview
Explore the profile of Zhenfeng Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Xu Y, Xia Q, Rao Q, Shi S, Shi Q, Ma H, et al.
Tumour Biol
. 2015 Nov;
37(4):5171-83.
PMID: 26547587
Decorin (DCN), as an important component of the extracellular matrix (ECM), is a small leucine-rich proteoglycan and synthesized by fibroblasts. Although DCN is dysregulated in numerous cancer types, limited data...
12.
Shen Q, Pan Y, Yu B, Shi S, Liu B, Xu Y, et al.
Zhonghua Bing Li Xue Za Zhi
. 2015 Aug;
44(3):164-9.
PMID: 26268749
To explore the automated immunostainer screening anaplastic lymphoma kinase (ALK) gene fusion non-small cell lung cancer (NSCLC) and clinicopathological characteristics of the molecular subtype lung cancers. Methods Five hundred and...
13.
Xu Y, Rao Q, Xia Q, Shi S, Shi Q, Ma H, et al.
Int J Clin Exp Pathol
. 2015 Jun;
8(3):2690-9.
PMID: 26045774
TFE3 translocation renal cell carcinoma is a highly aggressive malignancy which often occurs primarily in children and young adults. The pathognomonic molecular lesion in this subtype is a translocation event...
14.
Rao Q, Shen Q, Shi S, Xia Q, Lu Z, Yu B, et al.
Zhonghua Bing Li Xue Za Zhi
. 2015 Jan;
43(11):728-31.
PMID: 25582249
Objective: To study the clinicopathological features, differential diagnosis and prognosis of clear cell papillary renal cell carcinoma (CCPRCC). Methods: The histological, immunohistochemical, and molecular features were studied in 11 cases...
15.
Li L, Xia Q, Rao Q, Liu B, Wu B, Shi S, et al.
Zhonghua Bing Li Xue Za Zhi
. 2014 Sep;
43(6):389-93.
PMID: 25208989
Objective: To study the immunophenotype and molecular genetics of epithelioid sarcoma (ES), INI1 expression and its role in differential diagnosis. Methods: Twenty cases of ES were retrieved from the archival...
16.
Li H, Shen Q, Xia Q, Shi S, Zhang R, Yu B, et al.
Zhonghua Bing Li Xue Za Zhi
. 2014 Sep;
43(6):370-4.
PMID: 25208985
Objective: To investigate the clinicopathologic features, immunohistochemic phenotypes and genetic alterations of extrapulmonary inflammatory myofibroblastic tumor (IMT) and the correlation with prognosis. Methods: Thirty cases of IMT with follow-up were...
17.
Wang Y, Li J, Tohti M, Hu Y, Wang S, Li W, et al.
J Exp Clin Cancer Res
. 2014 Jul;
33:56.
PMID: 25027022
Background: To study the expression of D2R, MGMT and VEGF for clinical significance in pituitary adenomas, and to predict the potential curative medical therapy of dopamine agonists, temozolomide and bevacizumab...
18.
Wang Y, Liu B, Xu Y, Zhang J, Xia Q, Yu B, et al.
Zhonghua Bing Li Xue Za Zhi
. 2014 Jun;
43(4):251-5.
PMID: 24915816
Objective: To study the expression, clinicopathologic correlation and prognostic significance of caveolin-1 in lung adenocarcinomas(LAC). Methods: Immunohistochemical study (EnVision method) for caveolin-1 and TTF-1 was carried out in 185 cases...
19.
Fan X, Liu B, Xu H, Yu B, Shi S, Zhang J, et al.
Hum Pathol
. 2013 Mar;
44(8):1499-507.
PMID: 23465272
Mutation analysis of epidermal growth factor receptor (EGFR) is essential in determining the therapeutic strategy for lung adenocarcinoma. Immunohistochemical (IHC) staining with EGFR mutation-specific antibodies of del E746-A750 in exon...
20.
Xu Y, Shi Q, Ma H, Zhou H, Lu Z, Yu B, et al.
Tumour Biol
. 2011 Dec;
33(2):475-83.
PMID: 22143937
In this study, we explore the association of thymidine kinase 1 (TK1) expression in tumour tissues with clinical pathological parameters and prognosis in patients with pathological T1 (pT1) lung adenocarcinoma....